CytoTronics Launches Neural Application for Pixel, Unleashing High-throughput Screening Capability in Drug Discovery for Neurological Disease

CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, launched its Neural application for Pixel systems today. A pioneering innovation for neurodegenerative disease and neurotoxicity research, the application enables high-throughput screening for drug discovery at unprecedented scale.